Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 2
57
Diseases
9,677
Unique genes
0.073
Avg. similarity score
Major depressive disorder
Most-connected disease (19 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Major depressive disorder
Schizophrenia
Diabetes mellitus type 2
Metabolic syndrome
Bipolar disorder
Attention deficit hyperactivity disorder
Alzheimer disease
Insomnia
Obesity
Parkinson disease
Substance abuse
Scoliosis
Color vision deficiency
Osteoarthritis
Dementia
Anxiety disorder
Mood disorder
Neurotic disorder
Post-traumatic stress disorder
Depression
Autism
Bipolar depression
Oligodendroglioma
Cannabis abuse
Gastroesophageal reflux disease
Irritable bowel syndrome
Ear disorder
retinitis pigmentosa 18
Oculocerebrodental syndrome
Panic disorder
Willis-ekbom disease
3-methylcrotonyl-coa carboxylase deficiency
Birk-aharoni syndrome
opsismodysplasia
Gout
Pemphigus foliaceus
Alopecia-neurological defects-endocrinopathy syndrome
Craniolenticulosutural dysplasia
Partial deletion of short arm of chromosome 3
SNUPN-related muscular dystrophy with or without multi-system involvement
inherited interstitial lung disease
Auroneurodental syndrome
Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder
Congenital lactase deficiency
Developmental delay with language and ocular abnormalities
Diabetes deafness developmental delay and short stature syndrome
Patellar tendinitis
Sedoheptulokinase deficiency
Deafness, y-linked
Glyoxalase ii deficiency
Phosphoribosylaminoimidazole carboxylase deficiency
Vacuolar neuromyopathy
Vibratory urticaria
Warsaw breakage syndrome
hydroxyprolinemia
pterin-4 alpha-carbinolamine dehydratase 1 deficiency
siddiqi syndrome
Member diseases (most connected first ‐ the cluster's core)
Top shared genes (genes linked to 2+ member diseases ‐ top 100 shown, download for all)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| FOXP2 | 21 / 57 | Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Autism and 17 more |
| BDNF | 20 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar depression and 16 more |
| DCC | 19 / 57 | Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Autism and 15 more |
| NCAM1 | 19 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar depression and 15 more |
| PDE4B | 19 / 57 | Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Autism and 15 more |
| RBFOX1 | 19 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 15 more |
| LSAMP | 18 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Cannabis abuse and 14 more |
| MAD1L1 | 18 / 57 | Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Autism and 14 more |
| SORCS3 | 18 / 57 | Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Autism and 14 more |
| TCF4 | 18 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 14 more |
| CNTNAP2 | 17 / 57 | Alzheimer disease, Autism, Bipolar disorder, Dementia and 13 more |
| SLC39A8 | 17 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 13 more |
| CACNA1C | 16 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar depression and 12 more |
| CADM2 | 16 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 12 more |
| CSMD1 | 16 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 12 more |
| DRD2 | 16 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 12 more |
| ERBB4 | 16 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Color vision deficiency and 12 more |
| IGSF11 | 16 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Cannabis abuse and 12 more |
| MAPT | 16 / 57 | Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Autism and 12 more |
| NRXN1 | 16 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 12 more |
| SOX5 | 16 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 12 more |
| ARHGAP15 | 15 / 57 | Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Autism and 11 more |
| BRINP1 | 15 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Bipolar disorder, Color vision deficiency and 11 more |
| DLG2 | 15 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Dementia and 11 more |
| GRM8 | 15 / 57 | Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Autism and 11 more |
| HTR1A | 15 / 57 | Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Autism and 11 more |
| NTM | 15 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Color vision deficiency and 11 more |
| NTRK2 | 15 / 57 | Alzheimer disease, Anxiety disorder, Autism, Bipolar depression and 11 more |
| PTPRD | 15 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Cannabis abuse, Dementia and 11 more |
| RELN | 15 / 57 | Alzheimer disease, Autism, Bipolar depression, Bipolar disorder and 11 more |
| SDK1 | 15 / 57 | Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Autism and 11 more |
| TENM4 | 15 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar depression and 11 more |
| ANK3 | 14 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar depression and 10 more |
| ASTN2 | 14 / 57 | Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Diabetes mellitus type 2 and 10 more |
| AUTS2 | 14 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 10 more |
| COMT | 14 / 57 | Attention deficit hyperactivity disorder, Autism, Bipolar depression, Bipolar disorder and 10 more |
| FHIT | 14 / 57 | Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Color vision deficiency and 10 more |
| NPAS3 | 14 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 10 more |
| NRXN3 | 14 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 10 more |
| PLCL2 | 14 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Cannabis abuse and 10 more |
| RUNX1T1 | 14 / 57 | Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Cannabis abuse and 10 more |
| TLR4 | 14 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Diabetes mellitus type 2 and 10 more |
| TRPS1 | 14 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Color vision deficiency, Dementia and 10 more |
| VRK2 | 14 / 57 | Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Cannabis abuse and 10 more |
| AKAP6 | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 9 more |
| APOE | 13 / 57 | Alzheimer disease, Anxiety disorder, Bipolar disorder, Dementia and 9 more |
| CDH13 | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Color vision deficiency and 9 more |
| CELF4 | 13 / 57 | Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Color vision deficiency and 9 more |
| ERCC4 | 13 / 57 | Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Color vision deficiency and 9 more |
| GRIK2 | 13 / 57 | Alzheimer disease, Autism, Bipolar depression, Bipolar disorder and 9 more |
| IMMP2L | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 9 more |
| LRFN5 | 13 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 9 more |
| MACROD2 | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 9 more |
| METTL15 | 13 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 9 more |
| NEGR1 | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 9 more |
| NKAIN2 | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Color vision deficiency and 9 more |
| NLGN1 | 13 / 57 | Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Diabetes mellitus type 2 and 9 more |
| NYAP2 | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Dementia, Diabetes mellitus type 2 and 9 more |
| PCDH15 | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Color vision deficiency and 9 more |
| PTPRN2 | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Dementia and 9 more |
| RARB | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 9 more |
| RERE | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 9 more |
| SEMA6D | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Cannabis abuse and 9 more |
| SGCZ | 13 / 57 | Attention deficit hyperactivity disorder, Autism, Color vision deficiency, Diabetes mellitus type 2 and 9 more |
| TENM2 | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 9 more |
| THSD7A | 13 / 57 | Alzheimer disease, Anxiety disorder, Bipolar depression, Bipolar disorder and 9 more |
| TMEM106B | 13 / 57 | Alzheimer disease, Anxiety disorder, Bipolar disorder, Dementia and 9 more |
| ZBTB20 | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 9 more |
| ZNF804A | 13 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 9 more |
| ASB3 | 12 / 57 | Alzheimer disease, Color vision deficiency, Dementia, Diabetes mellitus type 2 and 8 more |
| BANK1 | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 8 more |
| C6ORF118 | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Color vision deficiency and 8 more |
| CAMK1D | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Color vision deficiency and 8 more |
| CARMIL1 | 12 / 57 | Autism, Bipolar disorder, Color vision deficiency, Gastroesophageal reflux disease and 8 more |
| CTTNBP2 | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 8 more |
| EFNA5 | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 8 more |
| ESR1 | 12 / 57 | Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder, Bipolar disorder and 8 more |
| FSTL5 | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar depression and 8 more |
| GLIS3 | 12 / 57 | Alzheimer disease, Color vision deficiency, Dementia, Diabetes mellitus type 2 and 8 more |
| GRIA1 | 12 / 57 | Alzheimer disease, Autism, Bipolar disorder, Diabetes mellitus type 2 and 8 more |
| GRIK3 | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 8 more |
| H2BC4 | 12 / 57 | Alzheimer disease, Autism, Bipolar disorder, Diabetes mellitus type 2 and 8 more |
| HTR2A | 12 / 57 | Autism, Bipolar depression, Bipolar disorder, Color vision deficiency and 8 more |
| IGSF9B | 12 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 8 more |
| LINGO2 | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Color vision deficiency and 8 more |
| MAGI2 | 12 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Bipolar disorder, Cannabis abuse and 8 more |
| MDGA2 | 12 / 57 | Attention deficit hyperactivity disorder, Color vision deficiency, Diabetes mellitus type 2, Insomnia and 8 more |
| NAALADL2 | 12 / 57 | Alzheimer disease, Autism, Bipolar disorder, Color vision deficiency and 8 more |
| NALF1 | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 8 more |
| NCOA5 | 12 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 8 more |
| NT5C2 | 12 / 57 | Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Cannabis abuse and 8 more |
| OLFM1 | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Color vision deficiency, Dementia and 8 more |
| PCDH9 | 12 / 57 | Autism, Dementia, Diabetes mellitus type 2, Gastroesophageal reflux disease and 8 more |
| PCLO | 12 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 8 more |
| PLCL1 | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder and 8 more |
| PRKN | 12 / 57 | Alzheimer disease, Autism, Color vision deficiency, Dementia and 8 more |
| RIMS1 | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar depression and 8 more |
| SLC6A4 | 12 / 57 | Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Bipolar depression and 8 more |
| SNX29 | 12 / 57 | Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Color vision deficiency and 8 more |
| TCF7L2 | 12 / 57 | Alzheimer disease, Autism, Bipolar disorder, Color vision deficiency and 8 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
None of these pathways reaches significance (all FDR q ≥ 0.05). They’re the best candidates found, but treat them as weak evidence for why this cluster groups together.
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Unblocking of NMDA receptors, glutamate binding and activation | Reactome | 22 / 22 | 1.2× | 8.60e-3 | 6.27e-2 |
| Type I diabetes mellitus | KEGG | 41 / 44 | 1.2× | 1.87e-2 | 9.88e-2 |
| Uptake and function of anthrax toxins | Reactome | 13 / 13 | 1.2× | 6.02e-2 | 1.89e-1 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | Reactome | 12 / 12 | 1.2× | 7.48e-2 | 2.12e-1 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | Reactome | 12 / 12 | 1.2× | 7.48e-2 | 2.12e-1 |
| Activation of Ca-permeable Kainate Receptor | Reactome | 12 / 12 | 1.2× | 7.48e-2 | 2.12e-1 |
| Drug metabolism - cytochrome P450 | KEGG | 64 / 73 | 1.1× | 7.72e-2 | 2.15e-1 |
| cGMP effects | Reactome | 11 / 11 | 1.2× | 9.28e-2 | 2.38e-1 |
| Signaling by ERBB4 | Reactome | 11 / 11 | 1.2× | 9.28e-2 | 2.38e-1 |
| Tryptophan catabolism | Reactome | 11 / 11 | 1.2× | 9.28e-2 | 2.38e-1 |
| Signaling by activated point mutants of FGFR1 | Reactome | 11 / 11 | 1.2× | 9.28e-2 | 2.38e-1 |
| Maturity onset diabetes of the young | KEGG | 24 / 26 | 1.1× | 9.50e-2 | 2.41e-1 |
| Downstream signaling of activated FGFR1 | Reactome | 17 / 18 | 1.2× | 1.09e-1 | 2.60e-1 |
| PI3K events in ERBB4 signaling | Reactome | 10 / 10 | 1.2× | 1.15e-1 | 2.68e-1 |
| Cocaine addiction | KEGG | 43 / 49 | 1.1× | 1.35e-1 | 2.92e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| nervous system development | GO:0007399 | 450 / 631 | 1.4× | 2.17e-24 | 6.21e-21 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 781 / 1,208 | 1.2× | 7.04e-21 | 1.29e-17 ✓ sig. |
| modulation of chemical synaptic transmission | GO:0050804 | 106 / 121 | 1.7× | 4.66e-17 | 4.80e-14 ✓ sig. |
| chemical synaptic transmission | GO:0007268 | 182 / 236 | 1.5× | 6.12e-16 | 5.01e-13 ✓ sig. |
| response to hypoxia | GO:0001666 | 141 / 176 | 1.5× | 4.29e-15 | 3.01e-12 ✓ sig. |
| axon guidance | GO:0007411 | 149 / 192 | 1.5× | 1.05e-13 | 5.77e-11 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 501 / 778 | 1.2× | 2.77e-13 | 1.43e-10 ✓ sig. |
| response to xenobiotic stimulus | GO:0009410 | 184 / 248 | 1.4× | 2.84e-13 | 1.46e-10 ✓ sig. |
| cell population proliferation | GO:0008283 | 191 / 263 | 1.4× | 2.91e-12 | 1.21e-9 ✓ sig. |
| positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | GO:0051897 | 162 / 217 | 1.4× | 3.13e-12 | 1.29e-9 ✓ sig. |
| xenobiotic metabolic process | GO:0006805 | 98 / 120 | 1.6× | 7.56e-12 | 2.85e-9 ✓ sig. |
| social behavior | GO:0035176 | 54 / 58 | 1.8× | 8.62e-12 | 3.21e-9 ✓ sig. |
| positive regulation of MAPK cascade | GO:0043410 | 165 / 224 | 1.4× | 1.30e-11 | 4.67e-9 ✓ sig. |
| neuron migration | GO:0001764 | 105 / 132 | 1.5× | 3.08e-11 | 9.96e-9 ✓ sig. |
| regulation of postsynaptic membrane potential | GO:0060078 | 54 / 59 | 1.8× | 5.02e-11 | 1.55e-8 ✓ sig. |